News Agency
Men's Weekly

Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy

  • Written by PR Newswire

SHANGHAI, Nov. 5, 2023 /PRNewswire/ -- On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clinical trials will be carried out simultaneously...

Read more: Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer...

Your Post-Study Work Visa Could Do More Than You Think — If You Use It Right

Completing your education in Australia is a great milestone, but every international graduate has to face the infamous: what's next? For some, the Temporary Graduate Visa (subclass 485) appears to be the next logical step as it allows you to... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion